Back to top
more

Surgery Partners (SGRY)

(Delayed Data from NSDQ)

$33.69 USD

33.69
5,241,283

+5.05 (17.63%)

Updated Aug 23, 2024 03:59 PM ET

After-Market: $33.75 +0.06 (0.18%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 41% (148 out of 251)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Surgery Partners (SGRY) Q4 Earnings Lag Estimates

by Zacks Equity Research

Surgery Partners (SGRY) delivered earnings and revenue surprises of -16.67% and 2.60%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Surgery Partners (SGRY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Are You Looking for a Top Momentum Pick? Why Surgery Partners (SGRY) is a Great Choice

by Zacks Equity Research

Does Surgery Partners (SGRY) have what it takes to be a top stock pick for momentum investors? Let's find out.

Brian Bolan headshot

Zendesk (ZEN), Surgery Partners (SGRY) and Tesla (TSLA) Are Aggressive Growth Stocks

by Brian Bolan

A look a three names on your aggressive growth stock radar screen.

Moving Average Crossover Alert: Surgery Partners

by Zacks Equity Research

Surgery Partners is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

Will Surgery Partners Continue to Surge Higher?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor in Surgery Partners.

Surgery Partners (SGRY) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Surgery Partners (SGRY) delivered earnings and revenue surprises of 0.00% and 0.04%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Surgery Partners (SGRY) Q3 Earnings Expected to Decline

by Zacks Equity Research

Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Surgery Partners (SGRY) Reports Q2 Loss, Lags Revenue Estimates

by Zacks Equity Research

Surgery Partners (SGRY) delivered earnings and revenue surprises of -70.59% and -0.93%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Surgery Partners (SGRY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

by Zacks Equity Research

Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Surgery Partners (SGRY) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Surgery Partners (SGRY) delivered earnings and revenue surprises of -40.00% and 0.25%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Surgery Partners (SGRY) Q1 Earnings Expected to Decline

by Zacks Equity Research

Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Tracey Ryniec headshot

5 Cheap Small Cap Stocks with Big Growth

by Tracey Ryniec

Stocks are selling off. Are you ready to look for some bargains?

Surgery Partners (SGRY) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Surgery Partners (SGRY) delivered earnings and revenue surprises of -20.00% and 2.96%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

    New Strong Sell Stocks for September 28th

    by Zacks Equity Research

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today: